ATA985A - Verfahren zur herstellung des neuen 2'-acetylery- thromycinstearates - Google Patents

Verfahren zur herstellung des neuen 2'-acetylery- thromycinstearates

Info

Publication number
ATA985A
ATA985A AT0000985A AT985A ATA985A AT A985 A ATA985 A AT A985A AT 0000985 A AT0000985 A AT 0000985A AT 985 A AT985 A AT 985A AT A985 A ATA985 A AT A985A
Authority
AT
Austria
Prior art keywords
thromycinstearate
acetylery
producing
new
acetylery thromycinstearate
Prior art date
Application number
AT0000985A
Other languages
English (en)
Other versions
AT386414B (de
Inventor
Martti Lauri Antero Marvola
Esko Veikko Marttila
Jaakko Antero Uotila
Aino Kyllikki Pippuri
Pekka Juhani Kairisalo
Erkki Juhani Honkanen
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of ATA985A publication Critical patent/ATA985A/de
Application granted granted Critical
Publication of AT386414B publication Critical patent/AT386414B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
AT0000985A 1984-01-06 1985-01-03 Verfahren zur herstellung des neuen 2'-acetylery- thromycinstearates AT386414B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (2)

Publication Number Publication Date
ATA985A true ATA985A (de) 1988-01-15
AT386414B AT386414B (de) 1988-08-25

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0000985A AT386414B (de) 1984-01-06 1985-01-03 Verfahren zur herstellung des neuen 2'-acetylery- thromycinstearates

Country Status (38)

Country Link
US (1) US4599326A (de)
JP (1) JPS60158197A (de)
KR (1) KR900006237B1 (de)
AT (1) AT386414B (de)
AU (1) AU565688B2 (de)
BE (1) BE901411A (de)
BG (1) BG43189A3 (de)
CA (1) CA1224461A (de)
CH (1) CH666275A5 (de)
CS (1) CS247191B2 (de)
CY (1) CY1462A (de)
DE (1) DE3500179A1 (de)
DK (1) DK149776C (de)
ES (1) ES8605818A1 (de)
FI (1) FI77249C (de)
FR (1) FR2557878B1 (de)
GB (1) GB2152502B (de)
HK (1) HK11590A (de)
HU (1) HU196221B (de)
IE (1) IE57967B1 (de)
IL (1) IL73885A (de)
IS (1) IS2968A7 (de)
IT (1) IT1184304B (de)
KE (1) KE3841A (de)
LU (1) LU85721A1 (de)
MA (1) MA20316A1 (de)
MX (1) MX156277A (de)
NL (1) NL8403979A (de)
NO (1) NO160263C (de)
NZ (1) NZ210606A (de)
PH (1) PH22471A (de)
PL (1) PL144349B1 (de)
PT (1) PT79777B (de)
RO (1) RO91262B (de)
SE (1) SE461854B (de)
SU (1) SU1410866A3 (de)
YU (1) YU44485B (de)
ZA (1) ZA8410143B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP4694207B2 (ja) * 2002-07-05 2011-06-08 コルジウム ファーマシューティカル, インコーポレイテッド オピオイドおよび他の薬物に関する乱用抑止性の薬学的組成物
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
AU2004285533A1 (en) * 2003-10-31 2005-05-12 Alza Corporation Compositions and dosage forms for enhanced absorption
CA2569958C (en) 2004-06-12 2016-03-22 Jane C. Hirsh Abuse-deterrent drug formulations
EP2457580A1 (de) 2004-08-25 2012-05-30 The UAB Research Foundation Absorptionsverbesserer zur Arzneimittelverabreichung
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2007149096A1 (en) 2006-06-23 2007-12-27 Aegis Therapeutics, Inc. Stabilizing alkylglycoside compositions and methods thereof
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
EP3566711A1 (de) 2011-05-18 2019-11-13 Eumederis Pharmaceuticals, Inc. Verbesserte peptidarzneimittel
EP2922877B1 (de) 2012-11-20 2018-09-05 Eumederis Pharmaceuticals, Inc. Verbesserte peptidarzneimittel
KR102213907B1 (ko) 2012-11-20 2021-02-09 메더리스 다이어비티즈, 엘엘씨 인슐린 저항성에 대한 개선된 펩티드 약제
WO2014140699A1 (en) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd A novel process of liberation of erythromycin and preparation of its salts
PL3155017T4 (pl) 2014-05-28 2024-06-17 Mederis Diabetes, Llc Ulepszone farmaceutyki peptydowe dla insulinooporności
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
CA3063717C (en) 2017-05-19 2021-08-24 Lunella Biotech, Inc. Antimitoscins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
WO2019108729A1 (en) 2017-12-01 2019-06-06 Lunella Biotech, Inc. Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells
RS63866B1 (sr) 2018-02-06 2023-01-31 Aegis Therapeutics Llc Intranazalne formulacije epinefrina i postupci za lečenje bolesti
BR112021011963A2 (pt) * 2018-12-17 2021-09-08 Lunella Biotech, Inc. Terapias de combinação tripla para alvejamento de mitocôndria e exterminação de células-tronco de câncer
JP7641897B2 (ja) * 2018-12-17 2025-03-07 ルネラ・バイオテック・インコーポレーテッド 抗加齢のための三剤組合せ療法
EA202091615A1 (ru) 2018-12-21 2021-03-05 Аегис Терапьютикс, Ллс Интраназальные составы на основе эпинефрина и способы лечения заболевания

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
MA20316A1 (fr) 1985-10-01
AU565688B2 (en) 1987-09-24
FR2557878A1 (fr) 1985-07-12
NZ210606A (en) 1987-08-31
AT386414B (de) 1988-08-25
HK11590A (en) 1990-02-23
CH666275A5 (de) 1988-07-15
RO91262A (ro) 1987-06-30
ZA8410143B (en) 1985-08-28
PT79777A (en) 1985-01-01
SU1410866A3 (ru) 1988-07-15
GB2152502B (en) 1987-10-07
KR900006237B1 (ko) 1990-08-27
NO160263B (no) 1988-12-19
SE8406671L (sv) 1985-07-07
CY1462A (en) 1989-07-21
IS2968A7 (is) 1985-04-03
JPH029040B2 (de) 1990-02-28
PL251457A1 (en) 1985-11-05
DK149776C (da) 1987-04-21
NO850007L (no) 1985-07-08
YU2085A (en) 1987-12-31
AU3705984A (en) 1985-07-11
IE850022L (en) 1985-07-06
ES8605818A1 (es) 1986-04-01
DE3500179C2 (de) 1989-08-24
FI77249B (fi) 1988-10-31
IT1184304B (it) 1987-10-28
CA1224461A (en) 1987-07-21
YU44485B (en) 1990-08-31
BE901411A (fr) 1985-04-16
FR2557878B1 (fr) 1988-01-15
JPS60158197A (ja) 1985-08-19
KR850005452A (ko) 1985-08-26
KE3841A (en) 1989-04-07
BG43189A3 (en) 1988-04-15
MX156277A (es) 1988-08-04
DK5884D0 (da) 1984-01-06
IL73885A (en) 1988-10-31
GB8432368D0 (en) 1985-02-06
FI850023L (fi) 1985-07-07
NO160263C (no) 1989-03-29
ES539349A0 (es) 1986-04-01
DK149776B (da) 1986-09-29
FI77249C (fi) 1989-02-10
CS247191B2 (en) 1986-12-18
FI850023A0 (fi) 1985-01-03
GB2152502A (en) 1985-08-07
SE8406671D0 (sv) 1984-12-28
PH22471A (en) 1988-09-12
NL8403979A (nl) 1985-08-01
US4599326A (en) 1986-07-08
HUT37628A (en) 1986-01-23
HU196221B (en) 1988-10-28
SE461854B (sv) 1990-04-02
LU85721A1 (fr) 1985-07-24
IE57967B1 (en) 1993-06-02
PT79777B (en) 1986-10-21
PL144349B1 (en) 1988-05-31
RO91262B (ro) 1987-07-01
IL73885A0 (en) 1985-03-31
DE3500179A1 (de) 1985-07-18
IT8519012A0 (it) 1985-01-04
DK5884A (da) 1985-07-07

Similar Documents

Publication Publication Date Title
AT383352B (de) Verfahren zur herstellung des neuen d-phenylalanyl-l-prolyl-l-arginin-aldehyd-sulfa s
AT386414B (de) Verfahren zur herstellung des neuen 2'-acetylery- thromycinstearates
ATA20485A (de) Verfahren zur herstellung von neuen tetrahydrocarbazol-derivaten
AT369750B (de) Verfahren zur herstellung des neuen 11-aza-4-0cladinosyl-6-0-desosaminyl-15-aethyl-7,13,14-
AT377524B (de) Verfahren zur herstellung von neuen anthracyclinglycosiden
AT382612B (de) Verfahren zur herstellung von neuen arylcyclobutylalkylaminen
AT388737B (de) Verfahren zur herstellung von neuen cyclosporinen
AT382156B (de) Verfahren zur herstellung von neuen cyclischen 9'-thiapeptidergotalkaloiden
AT384017B (de) Verfahren zur herstellung von neuen hydroxyaminoestern
ATA5985A (de) Verfahren zur herstellung von neuen 8alpha-acylaminoergolinen
AT386199B (de) Verfahren zur herstellung von neuen 2-piperazinopyrimidinen
ATA110486A (de) Verfahren zur herstellung des neuen 8-(4-(4-(1us850424726449
AT384226B (de) Verfahren zur herstellung von neuen 4'-halogenanthracyclinglykosiden
ATA160984A (de) Verfahren zur herstellung des neuen antitumor- antibiotikum-komplexes bbm-1675
ATA258985A (de) Verfahren zur herstellung von neuen substituierten 7-oxomitosanen
AT373892B (de) Verfahren zur herstellung des neuen kristallinen 1,1-dioxopenicillanoyloxymethyl-6-(d-alpha-amin
AT383597B (de) Verfahren zur herstellung des neuen n-(2-(((5it81081823546/8
DE3586741D1 (de) Verfahren zur herstellung von 5'-guanylsaeure.
AT382617B (de) Verfahren zur herstellung des neuen 17, 18 dehydroapovincaminol - 3',4',5' trimethoxybenzoats und seiner saeureadditionssalze
AT384214B (de) Verfahren zur herstellung von neuen mercaptoacylcarnitinen
ATA192686A (de) Verfahren zur herstellung der neuen 7-(3-chlorhu8507162725/8
ATA52285A (de) Verfahren zur herstellung von neuen diazepinoindolen
ATA284985A (de) Verfahren zur herstellung von neuen carbapenemderivaten
ATA88387A (de) Verfahren zur herstellung des tripeptids arg-ala-arg
AT382365B (de) Verfahren zur herstellung des neuen acetyldicarnitindichlorids

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee